Matthew A Sherman

14PUBLICATIONS
28CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)AllergyAutoimmunityClinical pharmacology and therapeuticsMedical mycology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Oct 24, 2026
Belimumab with rituximab for the treatment of primary membranous nephropathy.

|Feb 10, 2025
Approach to Janus kinase inhibition for juvenile dermatomyositis among CARRA and PReS providers.

Matthew A Sherman, Rebecca Nicolai, Emily K Datyner

|Dec 20, 2024
Meeting report: Hidden links in autoimmunity.

Mireia Guerau-de-Arellano, Margaret A Morris, Matthew A Sherman

|Jun 27, 2024
Childhood Arthritis and Rheumatology Research Alliance Biologic Disease-Modifying Antirheumatic Drug Consensus Treatment Plans for Refractory Moderately Severe Juvenile Dermatomyositis.

Stacey E Tarvin, Matthew A Sherman, Hanna Kim

|Jan 25, 2024
Myositis-Associated Autoantibodies in Patients With Juvenile Myositis Are Associated With Refractory Disease and Mortality.

Matthew A Sherman, Payam Noroozi Farhadi, Katherine Pak

|Dec 07, 2023
Clinical Features and Immunogenetic Risk Factors Associated With Additional Autoantibodies in Anti-Transcriptional Intermediary Factor 1γ Juvenile-Onset Dermatomyositis.

Matthew A Sherman, Qingyuan Yang, Laura Gutierrez-Alamillo

Pageof 3

Frequent Collaborators

4 joint publications

Lisa G Rider

3 joint publications

Andrew L Mammen

2 joint publications

Willy A Flegel

2 joint publications

Margaret A Morris